Konopleva, Marina Y.; Roellig, Christoph; Cavenagh, Jamie; Deeren, Dries; Girshova, Larisa; Krauter, Juergen; Martinelli, Giovanni; Montesinos, Pau; Schaefer, Jonas A.; Ottmann, Oliver; Petrini, Mario; Pigneux, Arnaud; Rambaldi, Alessandro; Recher, Christian; Rodriguez-Veiga, Rebeca; Taussig, David; Vey, Norbert; Yoon, Sung-Soo; Ott, Marion; Muehlbauer, Susanne; Beckermann, Benjamin M.; Catalani, Olivier; Genevray, Magali; Mundt, Kirsten; Jamois, Candice; Fenaux, Pierre; Wei, Andrew H.

Economic Games: An Introduction and Guide for Research

COLLABRA-PSYCHOLOGY

IF3.2

2021-02-2664

MDM2 inhibition: an important step forward in cancer therapy

LEUKEMIA

IF13.4

2020-07-10260

PREAI

Bidding strategies in Austrian and German balancing power auctions

WILEY INTERDISCIPLINARY REVIEWS-ENERGY AND ENVIRONMENT

IF6

2018-05-2215

OAAI

An exploratory, open-label, randomized, multicenter study to investigate the pharmacodynamics of a glycoengineered antibody (imgatuzumab) and cetuximab in patients with operable head and neck squamous cell carcinoma

ANNALS OF ONCOLOGY

IF65.4

2017-11-0119

OAAI

Open-label, multicentre expansion cohort to evaluate imgatuzumab in pre-treated patients with KRAS-mutant advanced colorectal carcinoma

EUROPEAN JOURNAL OF CANCER

IF7.1

2014-02-0126

PREAI

Insertion Sites in Engrafted Cells Cluster Within a Limited Repertoire of Genomic Areas After Gammaretroviral Vector Gene Therapy

MOLECULAR THERAPY

IF12

2011-11-0140

OAAI

Deichmann, Annette; Brugman, Martijn H.; Bartholomae, Cynthia C.; Schwarzwaelder, Kerstin; Verstegen, Monique M. A.; Howe, Steven J.; Arens, Anne; Ott, Marion G.; Hoelzer, Dieter; Seger, Reinhard; Grez, Manuel; Hacein-Bey-Abina, Salima; Cavazzana-Calvo, Marina; Fischer, Alain; Paruzynski, Anna; Gabriel, Richard; Glimm, Hanno; Abel, Ulrich; Cattoglio, Claudia; Mavilio, Fulvio; Cassani, Barbara; Aiuti, Alessandro; Dunbar, Cynthia E.; Baum, Christopher; Gaspar, H. Bobby; Thrasher, Adrian J.; von Kalle, Christof; Schmidt, Manfred; Wagemaker, Gerard

Humoral response to catumaxomab correlates with clinical outcome: Results of the pivotal phase II/III study in patients with malignant ascites

INTERNATIONAL JOURNAL OF CANCER

IF4.7

2011-09-2774

OAAI

Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease

NATURE MEDICINE

IF50

2010-01-24693

OAAI

Stein, Stefan; Ott, Marion G.; Schultze-Strasser, Stephan; Jauch, Anna; Burwinkel, Barbara; Kinner, Andrea; Schmidt, Manfred; Kraemer, Alwin; Schwaeble, Joachim; Glimm, Hanno; Koehl, Ulrike; Preiss, Carolin; Ball, Claudia; Martin, Hans; Goehring, Gudrun; Schwarzwaelder, Kerstin; Hofmann, Wolf-Karsten; Karakaya, Kadin; Tchatchou, Sandrine; Yang, Rongxi; Reinecke, Petra; Kuehlcke, Klaus; Schlegelberger, Brigitte; Thrasher, Adrian J.; Hoelzer, Dieter; Seger, Reinhard; von Kalle, Christof; Grez, Manuel

Advances in the treatment of chronic granulomatous disease by gene therapy

CURRENT GENE THERAPY

IF3.3

2007-06-0145

PREAI

In Vivo Expansion of MDS1/EVI1, PRDM16 and SETBP1 Integration Clones in Successful Chronic Granulomatous Disease (CGD) Gene Therapy Trial

MOLECULAR THERAPY

IF12

2006-01-010

OAAI

Marion Ott

个人简介

教育背景

工作经历

荣誉奖项

研究方向